LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology’s licensing partner CANbridge Pharmaceuticals has received regulatory approval to market NERLYNX (neratinib) in Mainland China.
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology’s licensing partner CANbridge Pharmaceuticals has received regulatory approval to market NERLYNX (neratinib) in Mainland China.
Copyright © 2023 Biotech Networks, LLC